NIKI CIK: 1734005

Niki BioSolutions, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
12.7
FY22:
7.07
FY23:
2.48
FY24:
0.96
FY25:
3.59
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.22
FY22:
13.8
FY23:
18.2
FY24:
15.2
FY25:
15.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
21.9
FY22:
20.9
FY23:
20.6
FY24:
16.1
FY25:
18.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.38
FY22:
12.5
FY23:
2.10
FY24:
4.34
FY25:
4.59
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0.53
FY23:
3.16
FY24:
0.01
FY25:
0.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.6
FY22:
15.7
FY23:
24.8
FY24:
21.1
FY25:
23.1

All amounts in millions USD Data source:SEC EDGAR